Health
Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition – News-Medical.net
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma….
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
Multiple myeloma is a type of blood cancer where immune cells grow in an uncontrolled…
-
Noosa News21 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News23 hours agoParkyn this, Parkyn that | Noosa Today
-
Noosa News20 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business19 hours ago3 steps to take to build a $1,000 monthly passive income